VIVARA RAGES: Open Payments
NPI 1023624699 · BETTENDORF, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$509 in 28 payments from 9 companies in 2025. Trend: 2023 $437 · 2024 $503 · 2025 $509
Food & beverage: $509
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC | 10 | $155 |
| AstraZeneca Pharmaceuticals LP | 7 | $140 |
| Novo Nordisk Inc | 5 | $101 |
| PFIZER INC. | 1 | $26 |
| Actelion Pharmaceuticals US, Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Dexcom, Inc. | 1 | $18 |
| Exact Sciences Corporation | 1 | $16 |
| Antares Pharma, Inc. | 1 | $14 |
Products named: MOUNJARO, FARXIGA, Wegovy, Ozempic, PREVNAR 20, AIRSUPRA, OPSUMIT, VIBERZI.
Industry payments across IA — which companies pay providers there.
